vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and Trip.com Group Ltd (TCOM). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $304.6M, roughly 1.1× Trip.com Group Ltd). Trip.com Group Ltd runs the higher net margin — 27.8% vs 4.0%, a 23.8% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
Trip.com Group Limited is a multinational travel agency headquartered in Shanghai, China. It is the largest online travel service provider in the world.
GRDN vs TCOM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.6M | $304.6M |
| Net Profit | $13.5M | $84.6M |
| Gross Margin | 22.7% | 78.8% |
| Operating Margin | 5.3% | 16.5% |
| Net Margin | 4.0% | 27.8% |
| Revenue YoY | 2.2% | — |
| Net Profit YoY | 46.1% | — |
| EPS (diluted) | $0.21 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.6M | — | ||
| Q4 25 | $397.6M | $304.6M | ||
| Q3 25 | $377.4M | — | ||
| Q2 25 | $344.3M | — | ||
| Q1 25 | $329.3M | — | ||
| Q3 24 | $314.4M | — | ||
| Q2 24 | — | $242.7M | ||
| Q2 23 | — | $214.5M |
| Q1 26 | $13.5M | — | ||
| Q4 25 | $20.9M | $84.6M | ||
| Q3 25 | $9.8M | — | ||
| Q2 25 | $9.0M | — | ||
| Q1 25 | $9.4M | — | ||
| Q3 24 | $-122.0M | — | ||
| Q2 24 | — | $73.8M | ||
| Q2 23 | — | $12.6M |
| Q1 26 | 22.7% | — | ||
| Q4 25 | 21.5% | 78.8% | ||
| Q3 25 | 19.8% | — | ||
| Q2 25 | 19.8% | — | ||
| Q1 25 | 19.5% | — | ||
| Q3 24 | 19.4% | — | ||
| Q2 24 | — | 81.8% | ||
| Q2 23 | — | 82.0% |
| Q1 26 | 5.3% | — | ||
| Q4 25 | 7.7% | 16.5% | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.9% | — | ||
| Q3 24 | -33.3% | — | ||
| Q2 24 | — | 27.8% | ||
| Q2 23 | — | 26.4% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.3% | 27.8% | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.9% | — | ||
| Q3 24 | -38.8% | — | ||
| Q2 24 | — | 30.4% | ||
| Q2 23 | — | 5.9% |
| Q1 26 | $0.21 | — | ||
| Q4 25 | — | $0.12 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $0.11 | ||
| Q2 23 | — | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $64.9M | $10.8B |
| Total DebtLower is stronger | — | $4.2B |
| Stockholders' EquityBook value | $232.4M | $23.8B |
| Total Assets | $426.9M | $36.9B |
| Debt / EquityLower = less leverage | — | 0.18× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $64.9M | — | ||
| Q4 25 | $65.6M | $10.8B | ||
| Q3 25 | $36.5M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $14.0M | — | ||
| Q3 24 | $37.2M | — | ||
| Q2 24 | — | $12.4B | ||
| Q2 23 | — | $7.6B |
| Q1 26 | — | — | ||
| Q4 25 | $0 | $4.2B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | $8.2B | ||
| Q2 23 | — | $7.2B |
| Q1 26 | $232.4M | — | ||
| Q4 25 | $217.9M | $23.8B | ||
| Q3 25 | $195.5M | — | ||
| Q2 25 | $179.7M | — | ||
| Q1 25 | $163.2M | — | ||
| Q3 24 | $133.9M | — | ||
| Q2 24 | — | $18.1B | ||
| Q2 23 | — | $16.3B |
| Q1 26 | $426.9M | — | ||
| Q4 25 | $412.7M | $36.9B | ||
| Q3 25 | $390.0M | — | ||
| Q2 25 | $356.3M | — | ||
| Q1 25 | $334.0M | — | ||
| Q3 24 | $348.0M | — | ||
| Q2 24 | — | $34.2B | ||
| Q2 23 | — | $30.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.00× | 0.18× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | 0.45× | ||
| Q2 23 | — | 0.44× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.45× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $6.1M | — | ||
| Q4 25 | $34.6M | — | ||
| Q3 25 | $28.2M | — | ||
| Q2 25 | $19.9M | — | ||
| Q1 25 | $17.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $24.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
| Q1 26 | 0.45× | — | ||
| Q4 25 | 1.65× | — | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
TCOM
| Others | $273.0M | 90% |
| Other | $31.6M | 10% |
